鶹ýӰ

Meeting Coverage

Additional Meetings

Don't Rule Out Breast Cancer Surgery for 90-Year-Olds

Retrospective study suggests survival benefit over conservative management

A photo of surgeons performing breast cancer surgery.

Latest Additional Meetings Meeting Coverage

Cryoablation for Early-Stage Breast Cancer a Safe Option in Older Women

Breast cancer survival rate was 97% at 5 years

April 15, 2024
Bispecific Antibody Active in Heavily Treated Multiple Myeloma

Responses in 60% of patients who had received a median of five prior lines of therapy

August 30, 2022
Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumors

However, trial comparing robotic and open surgery was stopped early due to low enrollment

July 6, 2022
Methenamine Hippurate Could Be Alternative Treatment for Recurrent UTI

Study finds antiseptic agent non-inferior to daily, low-dose antibiotic prophylaxis

July 5, 2022
Screening, Early Detection Remain Keys to Lower Cancer Mortality

Presidential panel sets course to remove barriers, increase services, and improve uptake

May 5, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients?

Study finds positive lymph nodes not an indicator for chemotherapy

April 7, 2022
Which Came First: Low Testosterone Levels or Severe COVID-19?

Italian data suggest a dose-response association

July 12, 2021
Support for MRI-Targeted Biopsy in Prostate Cancer Screening

Large Swedish study showed the approach cut overdiagnosis, unnecessary biopsies

July 9, 2021
Response Soars With Anti-PD-1 Drug for HER2-Positive Stomach Cancer

Almost 50% relative increase in ORR with pembrolizumab plus trastuzumab and chemotherapy

July 8, 2021
PD-1 Inhibitor Boosts Survival in Treated Esophageal Cancer

Benefit with China-developed tislelizumab in all patients and EU-North American subgroup

July 6, 2021
Are Antibiotics Linked to Early-Onset Colorectal Cancer?

With cases increasing globally, researchers look to these commonly used drugs

July 3, 2021
'Clinically Meaningful' Survival Gain in Neuroendocrine Tumors

Near 1-year improvement with radionuclide agent misses statistical significance

July 1, 2021
Adjuvant Combo Boosts Survival in Resected Pancreatic Cancer

Four-month gain in OS with the addition of nab-paclitaxel to gemcitabine

June 30, 2021
Impressive Disease Control in Metastatic Triple-Negative Breast Cancer

ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate

May 14, 2021

Latest AAD Meeting Coverage